Table 12 Liquid biopsy in motor system cancers
From: Liquid biopsy in cancer: current status, challenges and future prospects
Cancer | Liquid biomarker | Origin | Tendency | Downstream target | Function | Reference |
|---|---|---|---|---|---|---|
| Â | EWSR1 Translocation | Plasma | up | Â | Efficacy monitoring biomarker | |
ctDNA | Plasma | up | Â | Prognostic biomarker | ||
EWSR1 fusion sequence | Plasma | up | Â | Efficacy monitoring biomarker | ||
miR-34b | Plasma | down | Â | Tumor aggressiveness biomarker | ||
miR-143/145 | Plasma | down | FSCN1 | Early diagnostic biomarker | ||
miR34a | Plasma | down | Â | Disease progression biomarker, Efficacy monitoring biomarker |
